New Study Explore Safety Treatment for Heart Failure- Pipeline Review, H1 2018
Heart Failure
PUNE, MAHARASHTRA, INDIA, February 19, 2018 /EINPresswire.com/ -- Heart Failure
Overview
Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver or abdomen, swollen feet and ankles and weight gain.
There are two types of heart failure including systolic heart failure (left ventricle loses its ability to contract normally) and diastolic heart failure (left ventricle loses its ability to relax normally). The predisposing factors include high blood pressure, diabetes, sleep apnea, alcohol use and irregular heartbeats. Treatment includes surgery, vasodilator, beta blockers and diuretics.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2989076-congestive-heart-failure-heart-failure-pipeline-review-h1-2018
Top Companies mentioned
Athersys Inc
Bayer AG
Celixir Ltd
Daiichi Sankyo Co Ltd
Hoffmann-La Roche Ltd
Ironwood Pharmaceuticals Inc
Juventas Therapeutics Inc
La Jolla Pharmaceutical Company
Mitsubishi Tanabe Pharma Corp
Heart Failure Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Heart Failure - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Heart Failure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects.
The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 14, 28, 19, 3, 49, 13 and 1 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 21 and 4 molecules, respectively..
Heart Failure - Competitive Analysis
Key players are making innovative developments in Heart Failure industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Heart Failure.
The pipeline guide reviews pipeline therapeutics for Heart Failure by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Heart Failure therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Heart Failure therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Heart Failure.
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2989076-congestive-heart-failure-heart-failure-pipeline-review-h1-2018
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
